These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22860692)

  • 1. Low rate of secondary prevention ICDs in the general population: multiple-year multiple-source surveillance of sudden cardiac death in the Oregon Sudden Unexpected Death Study.
    Havmoeller R; Reinier K; Teodorescu C; Uy-Evanado A; Mariani R; Gunson K; Jui J; Chugh SS
    J Cardiovasc Electrophysiol; 2013 Jan; 24(1):60-5. PubMed ID: 22860692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community.
    Chugh SS; Jui J; Gunson K; Stecker EC; John BT; Thompson B; Ilias N; Vickers C; Dogra V; Daya M; Kron J; Zheng ZJ; Mensah G; McAnulty J
    J Am Coll Cardiol; 2004 Sep; 44(6):1268-75. PubMed ID: 15364331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community.
    Narayanan K; Reinier K; Uy-Evanado A; Teodorescu C; Chugh H; Marijon E; Gunson K; Jui J; Chugh SS
    Circulation; 2013 Oct; 128(16):1733-8. PubMed ID: 24048201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
    Silka MJ; Kron J; Dunnigan A; Dick M
    Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.
    Anderson KP
    J Interv Card Electrophysiol; 2005 Nov; 14(2):71-8. PubMed ID: 16374553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sudden cardiac death and automated external defibrillators. Where we are in 2012?].
    Trappe HJ
    Herz; 2012 Jun; 37(4):416-23. PubMed ID: 22669309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitachyarrhythmic interventions of implantable cardioverter-defibrillator in primary and secondary sudden cardiac death prevention patients].
    Piekarz J; Rydlewska A; Majewski J; Lelakowski J
    Pol Merkur Lekarski; 2012 Jun; 32(192):368-73. PubMed ID: 22891561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Maron MS; Rowin EJ; Wessler BS; Mooney PJ; Fatima A; Patel P; Koethe BC; Romashko M; Link MS; Maron BJ
    JAMA Cardiol; 2019 Jul; 4(7):644-657. PubMed ID: 31116360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular tachycardia and sudden death after primary PCI-reperfusion therapy: impact on primary prevention of sudden cardiac death.
    Paranskaya L; Akin I; Chatterjee T; Ritz A; Paranski P; Rehders T; Ince H; Schneider H; Nienaber CA; Bänsch D
    Herzschrittmacherther Elektrophysiol; 2011 Dec; 22(4):243-8. PubMed ID: 22124800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of ventricular tachyarrhythmias following improvement of left ventricular ejection fraction in patients with implantable cardiac defibrillators implanted for primary prevention of sudden cardiac death.
    Pillarisetti J; Gopinathannair R; Haney MJ; Abazid B; Rawasia W; Reddy MY; Adabala N; Bommana S; Emert M; Lakkireddy D
    J Interv Card Electrophysiol; 2017 Apr; 48(3):283-289. PubMed ID: 28150095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.
    Waks JW; Hamilton C; Das S; Ehdaie A; Minnier J; Narayan S; Niebauer M; Raitt M; Tompkins C; Varma N; Chugh S; Tereshchenko LG
    J Interv Card Electrophysiol; 2018 Jun; 52(1):77-89. PubMed ID: 29541969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.
    Thavikulwat AC; Tomson TT; Knight BP; Bonow RO; Choudhury L
    J Cardiovasc Electrophysiol; 2016 Aug; 27(8):953-60. PubMed ID: 27138377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study.
    Dubner S; Valero E; Pesce R; Zuelgaray JG; Mateos JC; Filho SG; Reyes W; Garillo R
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):420-8. PubMed ID: 16255752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.
    Magnusson P; Gadler F; Liv P; Mörner S
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1088-94. PubMed ID: 26178879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.